Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Emerging Company Profile

Prime Medicine: adding versatility to gene editing

Emerging Company Profile: David Liu’s latest gene editing play is developing a next-generation platform to rewrite DNA

By Lauren Martz, Senior Editor
July 13, 2021 11:03 AM UTC

CRISPR-Cas9 gene editing has only started to scratch the surface of its clinical potential, but next-generation iterations including prime editing from new company Prime aren’t far behind.

Prime Medicine Inc. launched on Tuesday with $315 million in funding and a CRISPR-based technology that adds flexibility and potential safety benefits over other gene editing tools...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Beam Therapeutics Inc.

Prime Medicine Inc.